163 related articles for article (PubMed ID: 37377615)
1. Desmoplastic Reaction Associates with Prognosis and Adjuvant Chemotherapy Response in Colorectal Cancer: A Multicenter Retrospective Study.
Hu Q; Wang Y; Yao S; Mao Y; Liu L; Li Z; Chen Y; Zhang S; Li Q; Zhao Y; Fan X; Cui Y; Zhao K; Liu Z
Cancer Res Commun; 2023 Jun; 3(6):1057-1066. PubMed ID: 37377615
[TBL] [Abstract][Full Text] [Related]
2. A Multicenter Study of the Prognostic Value of Desmoplastic Reaction Categorization in Stage II Colorectal Cancer.
Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Kajiwara Y; Okamoto K; Mochizuki S; Tsujimoto H; Shinto E
Am J Surg Pathol; 2019 Aug; 43(8):1015-1022. PubMed ID: 31094924
[TBL] [Abstract][Full Text] [Related]
3. Desmoplastic Pattern at the Tumor Front Defines Poor-prognosis Subtypes of Colorectal Cancer.
Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J
Am J Surg Pathol; 2017 Nov; 41(11):1506-1512. PubMed ID: 28877064
[TBL] [Abstract][Full Text] [Related]
4. Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorization.
Ueno H; Sekine S; Oshiro T; Kanemitsu Y; Hamaguchi T; Shida D; Takashima A; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J; Shimada Y
Surgery; 2018 Apr; 163(4):777-783. PubMed ID: 29162344
[TBL] [Abstract][Full Text] [Related]
5. Histologic categorization of desmoplastic reaction: its relevance to the colorectal cancer microenvironment and prognosis.
Ueno H; Shinto E; Shimazaki H; Kajiwara Y; Sueyama T; Yamamoto J; Hase K
Ann Surg Oncol; 2015 May; 22(5):1504-12. PubMed ID: 25395146
[TBL] [Abstract][Full Text] [Related]
6. Pathological classification of desmoplastic reaction is prognostic factor in cervical adenocarcinoma.
Akimoto T; Takasawa A; Takasawa K; Aoyama T; Matsuura M; Tamate M; Iwasaki M; Habata S; Murakami T; Osanai M; Saito T
Med Mol Morphol; 2022 Dec; 55(4):275-282. PubMed ID: 35876908
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases.
Ao T; Kajiwara Y; Yonemura K; Shinto E; Mochizuki S; Okamoto K; Aosasa S; Ueno H
Virchows Arch; 2019 Sep; 475(3):341-348. PubMed ID: 31076902
[TBL] [Abstract][Full Text] [Related]
8. Morphological consistency of desmoplastic reactions between the primary colorectal cancer lesion and associated metastatic lesions.
Ao T; Kajiwara Y; Yonemura K; Shinto E; Mochizuki S; Okamoto K; Kishi Y; Ueno H
Virchows Arch; 2020 Jul; 477(1):47-55. PubMed ID: 31932918
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer.
Fan S; Cui X; Zheng L; Ma W; Zheng S; Wang J; Qi L; Ye Z
J Gastrointest Oncol; 2022 Dec; 13(6):2903-2921. PubMed ID: 36636094
[TBL] [Abstract][Full Text] [Related]
10. Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma.
Sakai A; Nakashima Y; Miyashita Y; Ao T; Kimura Y; Shinto E; Oki E; Shimokawa M; Ueno H; Oda Y; Mori M
Histopathology; 2021 Aug; 79(2):219-226. PubMed ID: 33595141
[TBL] [Abstract][Full Text] [Related]
11. Histologic categorization of fibrotic cancer stroma in the primary tumor is an independent prognostic index in resectable colorectal liver metastasis.
Ueno H; Konishi T; Ishikawa Y; Shimazaki H; Ueno M; Aosasa S; Saiura A; Hase K; Yamamoto J
Am J Surg Pathol; 2014 Oct; 38(10):1380-6. PubMed ID: 24832160
[TBL] [Abstract][Full Text] [Related]
12. Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer.
González IA; Bauer PS; Liu J; Chatterjee D
Histopathology; 2021 Jan; 78(2):252-264. PubMed ID: 32654226
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial).
Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Murotani K; Matsui S; Teramukai S; Sugai T; Ajioka Y; Maruo H; Kotaka M; Tsujie M; Munemoto Y; Yamaguchi T; Kuroda H; Fukunaga M; Tomita N; Sugihara K
Br J Cancer; 2021 Mar; 124(6):1088-1097. PubMed ID: 33414540
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Novel Prognostic Nomogram Combined With Desmoplastic Reaction for Synchronous Colorectal Peritoneal Metastasis.
Qin X; Zhao M; Deng W; Huang Y; Cheng Z; Chung JPW; Chen X; Yang K; Chan DYL; Wang H
Front Oncol; 2022; 12():826830. PubMed ID: 35359399
[TBL] [Abstract][Full Text] [Related]
16. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
17. Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.
Grosser B; Emmerson J; Reitsam NG; Cunningham D; Nankivell M; Langley RE; Allum WH; Trepel M; Märkl B; Grabsch HI
Br J Cancer; 2024 Feb; 130(3):457-466. PubMed ID: 38123705
[TBL] [Abstract][Full Text] [Related]
18. Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA).
Reitsam NG; Märkl B; Dintner S; Sipos E; Grochowski P; Grosser B; Sommer F; Eser S; Nerlinger P; Jordan F; Rank A; Löhr P; Waidhauser J
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765951
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of ADAM9.
Ao T; Mochizuki S; Kajiwara Y; Yonemura K; Shiraishi T; Nagata K; Shinto E; Okamoto K; Nearchou IP; Shimazaki H; Kishi Y; Okada Y; Ueno H
Int J Cancer; 2022 May; 150(10):1706-1721. PubMed ID: 35080810
[TBL] [Abstract][Full Text] [Related]
20. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
